Standardized Patient-Centered Medication Review in Home Hospice
Public ClinicalTrials.gov record NCT03972163. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Standardized PatiEnt-CenTered medicatiOn Review (SPECTORx) in Home Hospice
Study identification
- NCT ID
- NCT03972163
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- University of Massachusetts, Worcester
- Other
- Enrollment
- 23 participants
Conditions and interventions
Conditions
Interventions
- "Discontinuing Medication Appropriately" and "Understanding the Art of Communication about Deprescribing" Behavioral
- "Key Approaches to Support Informal Family Caregivers in Managing Medications" Behavioral
- NIA Medication Management - Active Comparator Behavioral
- STOPPFrail (Screening Tool of Older Persons Prescriptions) Behavioral
Behavioral
Eligibility (public fields only)
- Age range
- 65 Years to 110 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 14, 2020
- Primary completion
- Dec 30, 2022
- Completion
- Dec 30, 2023
- Last update posted
- May 20, 2025
2020 – 2023
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Care Dimensions | Danvers | Massachusetts | 01923 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03972163, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 20, 2025 · Synced May 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03972163 live on ClinicalTrials.gov.